Literature DB >> 2564951

Prevalence of diabetes and impaired glucose tolerance in rural Tanzania.

D G McLarty1, A B Swai, H M Kitange, G Masuki, B L Mtinangi, P M Kilima, W J Makene, L M Chuwa, K G Alberti.   

Abstract

The prevalence of diabetes mellitus and impaired glucose tolerance (IGT) was assessed by use of WHO diagnostic criteria in 6299 Africans aged 15 years and above living in six villages in Tanzania. 0.87% (1.1% male, 0.68% female) had diabetes and 7.8% (6.9% male, 7.7% female) had IGT. Prevalence rates were 1.1% and 8.4%, respectively, when age-adjusted to the USA population. Only 7 (13.5%) of the 53 individuals with diabetes had been known to have the disorder; 34 (74%) of the other 46 were symptom-free. Mean age was 54 (SD 20) for diabetic subjects and 37 (17) years for the whole population. Diabetes and IGT rates did not differ significantly between villages despite geographical, socioeconomic, and dietary differences. Diabetes rates increased modestly with age and body mass index (BMI). Fasting blood glucose (FBG) levels did not rise significantly with age but correlated positively with systolic blood pressure (BP) and negatively with haemoglobin concentration (Hb) and BMI. The 2 hour post-glucose load blood glucose values correlated positively with age, sex, and systolic BP and negatively with Hb. Diabetes is less prevalent in rural Africa than in developed countries, even when age has been corrected for. This difference is probably related to body weight, diet, and exercise.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564951     DOI: 10.1016/s0140-6736(89)92866-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

Review 1.  Impaired glucose tolerance.

Authors:  J S Yudkin; K G Alberti; D G McLarty; A B Swai
Journal:  BMJ       Date:  1990-09-01

2.  Diabetes in tropical Africa: a prospective study, 1981-7. I. Characteristics of newly presenting patients in Dar es Salaam, Tanzania, 1981-7.

Authors:  A B Swai; J Lutale; D G McLarty
Journal:  BMJ       Date:  1990-04-28

3.  Temporal trends in incidence of Type 1 diabetes between 1986 and 2006 in Brazil.

Authors:  C A Negrato; J P L Dias; M F Teixeira; A Dias; M H Salgado; J R Lauris; R M Montenegro; M B Gomes; L Jovanovic
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

4.  Preventing Diabetes and Atherosclerosis in Sub-Saharan Africa: Should the Metabolic Syndrome Have a Role?

Authors:  Omoye E Imoisili; Anne E Sumner
Journal:  Curr Cardiovasc Risk Rep       Date:  2009-01-01

5.  Angiotensin-converting enzyme gene polymorphisms and T2DM in a case-control association study of the Bahraini population.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Emad M Masuadi; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-01-05       Impact factor: 3.396

6.  Known type 2 diabetes mellitus among the Kuwaiti population. A prevalence study.

Authors:  N Abdella; M Khogali; S al-Ali; K Gumaa; J Bajaj
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

7.  Rural to urban migration and changes in cardiovascular risk factors in Tanzania: a prospective cohort study.

Authors:  Nigel Unwin; Peter James; Dorothy McLarty; Harun Machybia; Peter Nkulila; Bushiri Tamin; Mkay Nguluma; Richard McNally
Journal:  BMC Public Health       Date:  2010-05-24       Impact factor: 3.295

8.  Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia.

Authors:  Mario Azevedo; Sridevi Alla
Journal:  Int J Diabetes Dev Ctries       Date:  2008-10

9.  Coronary heart disease risk factors in sub-Saharan Africa: studies in Tanzanian adolescents.

Authors:  H M Kitange; A B Swai; G Masuki; P M Kilima; K G Alberti; D G McLarty
Journal:  J Epidemiol Community Health       Date:  1993-08       Impact factor: 3.710

10.  Prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban adults in Nigeria.

Authors:  S T Olatunbosun; P O Ojo; N S Fineberg; A F Bella
Journal:  J Natl Med Assoc       Date:  1998-05       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.